SYN2315201

SynDRA canonical compound SYN2315201 — structure-anchored drug synonym record

Clinical phase	Phase 1
Primary target(s)	MAPK1 \| MAPK3
Mechanism of action	MAP kinase inhibitor

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

MDM2

Cross-references

PubChem CID: 90331177
ChEMBL: CHEMBL5183609

Synonyms

CC-90003
CC90003
orb1308484
SCHEMBL15938533
SCHEMBL29392962
C22H21F3N6O2
ILUKRINUNLAVMH-UHFFFAOYSA-N
BDBM351000
GLXC-25740
EX-A4704
US9796700, Compound I-90
MFCD31692404
NSC808792
s8801
AKOS040741517
NSC-808792
NCGC00601809-01
AC-35715
MS-28376
SY237712
DB-101574
HY-112570
CS-0046792
G16389
T14894

Look up SYN2315201 in the interactive SynDRA portal →